Wednesday, July 8, 2026

pharma · Multiple Myeloma · Ovarian Cancer · CASIF

CASI Pharmaceuticals

News and analysis for CASI Pharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

601 Gateway Blvd, San Francisco, CA 94080, US HQ
44 Employees
Public company Type
CASIF · NYSE Ticker
Company details
Status
Public
HQ
601 Gateway Blvd, San Francisco, CA 94080, US
Employees
44
Programs
22
Drugs
11
Patents
2
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning CASI Pharmaceuticals — regulatory, clinical, and market coverage.

News and analysis for CASI Pharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning CASI Pharmaceuticals yet.

Back to company overview →